Retatrutide + Tirzepatide Blend
Replace with a real product or packaging photo before launch
Specification discussion
- Available specifications: 60 mg blend vials (20 + 40 mg) · 10 vials per box
- Batch documentation: COA; TDS / SDS where applicable
- Purity and analytical reporting defined per the agreed project specification
- Packaging, labeling, and sample quantities reviewed per B2B order
Supply is subject to buyer qualification and destination-market regulatory review. These products are not consumer offers and are not advertised to the public.